Abeona Therapeutics Inc vs Heron Therapeutics Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: Abeona Therapeutics Inc is far larger — about 6.9× Heron Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | HRTX | |
|---|---|---|
Market Cap | $421.19M | $61.47M |
Sector | Health | Health |
52-Week High | $7.45 | $1.49 |
52-Week Low | $4.17 | $0.32 |
Enterprise Value | $276.10M | $168.21M |
Trailing returns across standard periods
Latest headlines on both assets
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →